15-78616885-T-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000743.5(CHRNA3):c.377+139A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0247 in 604,794 control chromosomes in the GnomAD database, including 1,405 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.028 ( 227 hom., cov: 32)
Exomes 𝑓: 0.024 ( 1178 hom. )
Consequence
CHRNA3
NM_000743.5 intron
NM_000743.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.990
Publications
6 publications found
Genes affected
CHRNA3 (HGNC:1957): (cholinergic receptor nicotinic alpha 3 subunit) This locus encodes a member of the nicotinic acetylcholine receptor family of proteins. Members of this family of proteins form pentameric complexes comprised of both alpha and beta subunits. This locus encodes an alpha-type subunit, as it contains characteristic adjacent cysteine residues. The encoded protein is a ligand-gated ion channel that likely plays a role in neurotransmission. Polymorphisms in this gene have been associated with an increased risk of smoking initiation and an increased susceptibility to lung cancer. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
CHRNA3 Gene-Disease associations (from GenCC):
- urinary bladder, atony ofInheritance: AR Classification: STRONG Submitted by: Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.236 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CHRNA3 | NM_000743.5 | c.377+139A>T | intron_variant | Intron 4 of 5 | ENST00000326828.6 | NP_000734.2 | ||
| CHRNA3 | NM_001166694.2 | c.377+139A>T | intron_variant | Intron 4 of 5 | NP_001160166.1 | |||
| CHRNA3 | NR_046313.2 | n.579+139A>T | intron_variant | Intron 4 of 7 | ||||
| CHRNA3 | XM_006720382.4 | c.176+139A>T | intron_variant | Intron 4 of 5 | XP_006720445.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CHRNA3 | ENST00000326828.6 | c.377+139A>T | intron_variant | Intron 4 of 5 | 1 | NM_000743.5 | ENSP00000315602.5 | |||
| CHRNA3 | ENST00000348639.7 | c.377+139A>T | intron_variant | Intron 4 of 5 | 1 | ENSP00000267951.4 | ||||
| CHRNA3 | ENST00000559658.5 | n.377+139A>T | intron_variant | Intron 4 of 7 | 2 | ENSP00000452896.1 |
Frequencies
GnomAD3 genomes AF: 0.0282 AC: 4287AN: 152156Hom.: 225 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
4287
AN:
152156
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0236 AC: 10664AN: 452520Hom.: 1178 AF XY: 0.0221 AC XY: 5264AN XY: 238398 show subpopulations
GnomAD4 exome
AF:
AC:
10664
AN:
452520
Hom.:
AF XY:
AC XY:
5264
AN XY:
238398
show subpopulations
African (AFR)
AF:
AC:
796
AN:
12544
American (AMR)
AF:
AC:
100
AN:
18456
Ashkenazi Jewish (ASJ)
AF:
AC:
278
AN:
13662
East Asian (EAS)
AF:
AC:
8302
AN:
31034
South Asian (SAS)
AF:
AC:
339
AN:
44428
European-Finnish (FIN)
AF:
AC:
8
AN:
30538
Middle Eastern (MID)
AF:
AC:
16
AN:
1968
European-Non Finnish (NFE)
AF:
AC:
253
AN:
273830
Other (OTH)
AF:
AC:
572
AN:
26060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
417
833
1250
1666
2083
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0283 AC: 4302AN: 152274Hom.: 227 Cov.: 32 AF XY: 0.0288 AC XY: 2141AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
4302
AN:
152274
Hom.:
Cov.:
32
AF XY:
AC XY:
2141
AN XY:
74452
show subpopulations
African (AFR)
AF:
AC:
2672
AN:
41560
American (AMR)
AF:
AC:
122
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
58
AN:
3468
East Asian (EAS)
AF:
AC:
1276
AN:
5160
South Asian (SAS)
AF:
AC:
64
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
67
AN:
68014
Other (OTH)
AF:
AC:
40
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
201
402
603
804
1005
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.